- Merck (Harrisburg, PA)
- …identification of potential investigators for consideration for participating in phase II- IV clinical development programs + In response to unsolicited requests from ... of the United States Federal Drug Administration (FDA), Office of Inspector General (OIG), Health Insurance Portability and Accountability Act (HIPAA) and… more